BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 14, 2013
View Archived Issues
Preclinical and clinical safety data for EBI-005 presented
Read More
GTx-758 effectively suppresses testosterone in males with prostate cancer
Read More
BL-8030 shows potency, selectivity and a promising pharmacokinetic profile
Read More
Merck KGaA presents novel TGFR-1 inhibitor with in vivo antitumor activity
Read More
Lexicon advances LX-4211 to expansion portion of phase II trial
Read More
PRELUDE study of enzastaurin fails to meet primary endpoint
Read More
ALS Emergency Treatment Fund and Denovo Biomarkers establish partnership
Read More
Arno Therapeutics and Clarient to develop companion diagnostic
Read More
Serum CYPA as a novel biomarker of atherosclerotic diseases
Read More
Researchers develop novel vaccine with the potential to block tumor foci formation
Read More
Dainippon Sumitomo Pharma reflects on accomplishments of fiscal 2012
Read More
Chinese group presents new DHODH inhibitors
Read More
Novel compounds inhibiting deubiquitinating activity patented by Vivolux
Read More
Sirtris Pharmaceuticals discloses new hSIRT1 activators
Read More
Bayer Intellectual Property divulges novel HIF-1 inhibitors
Read More
Pan-genomic anti-HCV activity disclosed for tetrahydroquinolines
Read More
Novavax commences animal testing with H7N9 VLP influenza vaccine
Read More
FDA accepts Biogen Idec's Eloctate BLA for filing
Read More
Starpharma's SPL-7013 shows potential to treat viral conjunctivitis
Read More
Mirna Therapeutics advances miRNA MRX-34 into phase I
Read More
MorphoSys begins new phase II trial of MOR-208 in NHL
Read More
Actavis and Warner Chilcott discuss potential business combination
Read More
Relypsa completes enrollment in pivotal phase III trial of patiromer
Read More
FDA grants priority review to simeprevir NDA
Read More
FDA approves first nimodipine oral solution
Read More
Sorrento Therapeutics and Igdrasol acquire E.U. rights to Cynviloq
Read More